TrialCancer immunology, immunotherapy : CII2005

A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo.

Brigitte Gückel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.